Guidance

Contact MHRA

How to contact MHRA for specific services or enquiries.

Customer Services

10 South Colonnade
Canary Wharf
London
E14 4PU

View a map showing our location

Main Telephone (weekdays 9am to 5pm): 020 3080 6000

Fax: 0203 118 9803

info@mhra.gov.uk

To to reproduce or re-use any MHRA material see our guidance.

Enquiries about new guidance and procedures in place since 1 January 2021

For enquiries relating to the Agency’s planning and procedures since1 January 2021, see the below email contacts.

Importing and exporting

Marketing authorisations, variations and licensing guidance

Medicines for children

Pharmacovigilance

Regulatory and pharmacovigilance submissions

Medical devices

NIBSC

News centre

Press enquiries (including out of hours): 020 3080 7651

newscentre@mhra.gov.uk

Access Consortium

For more information please refer to our Access Consortium guidance.

For queries, or to submit an Expression of Interest form, please contact access-mhra@mhra.gov.uk.

Accounts receivable

Telephone: 020 3080 6533

sales.invoices@mhra.gov.uk

Accounts payable

Suppliers:

  • A to F – 0203 080 7166
  • G to L – 0203 080 6720
  • M to Z – 0203 080 7111

Accounts.Payable@mhra.gov.uk

Clinical trials of medicines

If you are checking the status of a clinical trial submission, have a general clinical trial query or a technical query regarding an application you have submitted or plan to make:

Telephone (weekdays 8:30am to 4:30pm): 020 3080 6456

clintrialhelpline@mhra.gov.uk

Defective medicines reporting centre

Email: dmrc@mhra.gov.uk

Report a defective medicine through the Yellow Card Scheme

DMRC (office hours) 020 3080 6574 (8:45am to 4:45pm Monday to Friday)

DMRC (out of hours) 07795 641 532 (urgent outside of normal working hours, at weekends or on public holidays)

Medical Devices

For enquiries relating to compliance issues for medical devices contact: Devices.compliance@mhra.gov.uk

Medicines enforcement

Enquiries about potential illegal dealings with medicines

Telephone (weekdays 9am to 5pm): 020 3080 6330

Email: thebureau@mhra.gov.uk

Report suspected falsified medicines via the Yellow Card Scheme

Telephone: 020 3080 6330 / 020 3080 6701

Email: fakemeds@mhra.gov.uk

Manufacturer and wholesale dealer licences (medicines)

Enquiries about applications for licences and registrations covering manufacturing, wholesaling, brokering and importing of medicines and active substances

Email: pcl@mhra.gov.uk

MHRA medicines portal

For enquiries about registering and submitting product licence applications using MHRA portal.

Telephone: 020 3080 7100

portal.manager@mhra.gov.uk

Regulatory information service (RIS)

RIS acts as the single main point of contact for marketing authorisation holders of medicines and their representatives.

Telephone (weekdays 9am to 5pm): 020 3080 7400

New licence applications : RIS.NA@mhra.gov.uk

Variations: variationqueries@mhra.gov.uk

PLPI (all application types): RIS.PLPI@mhra.gov.uk

Whistleblower referrals

Please contact the whistleblowing section if you are reporting on issues as an employee, ex-employee or third-party employee of the company or organisation in question.

Email: whistleblower@mhra.gov.uk

Telephone: 07778168204

All other enquiries about potential illegal dealings should go to Medicines Enforcement.

Enquiries about applications and registrations for Distance Selling Logo

Email: dsl@mhra.gov.uk

Data protection

For all data protection enquiries, contact: DataProtection@mhra.gov.uk

Published 28 May 2014
Last updated 14 February 2022 + show all updates
  1. Added Data Protection contact details

  2. Added information about COVID-19 and urgent regulatory flexibility enquiries over the Easter weekend.

  3. Added information about MHRA services and using email or telephone to contact us during the coronavirus (COVID-19) response period.

  4. Change of Accounts payable supplier contact phone numbers.

  5. Added a section on contacts for EU exit no deal enquiries.

  6. Added new contact details for Medical Devices.

  7. Added contact details for submission enquiries.

  8. Updated the contact information for the Clinical Trials helpline.

  9. Updated contact details

  10. Contact details for medicines enforcement updated.

  11. First published.